Company / Assets per Share
PUMA BIOTECHNOLOGY, INC. Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$4.40
FY2025
5-year range
$4.40 / $5.65
FY2021-FY2025
Trend
-1.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has declined for 5 consecutive years, from $6.23 in FY2020 to $4.40 in FY2025.
Based on SEC 10-K filings.
4.40 in FY2025 with a 5-year CAGR of -6.7%.
Declined from $4.97 to $4.40 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -6.5%
- 5-Year CAGR
- -6.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- PUMA BIOTECHNOLOGY, INC.'s assets per share has declined for 5 consecutive years.
- In FY2025, assets per share decreased 1.6% year-over-year.
- Peak assets per share was recorded in FY2018.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.40 | -1.6% |
| FY2024 | $4.48 | -10.0% |
| FY2023 | $4.97 | -7.8% |
| FY2022 | $5.39 | -4.6% |
| FY2021 | $5.65 | -9.3% |
| FY2020 | $6.23 | +1.6% |
| FY2019 | $6.13 | -11.1% |
| FY2018 | $6.89 | +53.3% |
| FY2017 | $4.49 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026